BioWorld

Oct. 27, 2014

CRO-sponsor partnerships require planning, time to develop

A report from Tufts Center for the Study of Drug Development (CSDD) highlights the evolving relationships between contract research organizations (CROs) and clinical trial sponsors through the adoption of strategic partnerships. Read More

Week in review

Word on the street

Week in Washington

Biotechnology company deals with other biotechnology companies: September 1 - October 23, 2014

Top 10 deals between biotech companies in 2014

Manufacturing, marketing and distribution agreements between biotech companies: September 1 - October 23, 2014

Biotech-biotech collaborations: modified agreements: September 1 - October 23, 2014

Money raised by biotech in 2014 vs. 2013

Money raised by biotech Jan. 1 - Oct. 23, 2014

The week's biggest gainers and losers

BioWorld stock report for public biotechnology companies

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...